A Brief Review of Traumatic Shock Leading to a New Theory and a New Treatment

Journal of Applied Research

Volumn 3, Issue 4, 2003, Pages 464-469

  Hardaway, Robert M ^a  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Disseminated intravascular coagulation; Hemorrhagic shock; Multiple organ failure; Traumatic shock

Indexed keywords

ACTIVATED PROTEIN C; CYTOKINE ANTIBODY; ENDORPHIN; ENDOTOXIN ANTIBODY; IBUPROFEN; INDOMETACIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; KETOCONAZOLE; MONOCLONAL ANTIBODY; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PENTOXIFYLLINE; SURFACTANT; THROMBIN INHIBITOR; VASOACTIVE AGENT;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; BATTLE INJURY; BLEEDING; BLOOD CLOTTING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; EXTRACORPOREAL CIRCULATION; FEMALE; HEMORRHAGIC SHOCK; HUMAN; MALE; MULTIPLE ORGAN FAILURE; NONHUMAN; SEPSIS; SHOCK; SHORT SURVEY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRAUMATIC SHOCK;

EID: 2342612088     PISSN: 1537064X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (17)

1. Le Dran HF. Observation de Chirurgie. Paris, France: 1731;2:253-254.
2. Hardaway RM. Shock: The Reversible Stage of Dying. Chicago, Ill: Mosby Year Book Publishers Inc; 1988:3, 262.
3. Barnes JK. Surgical History from The Medical and Surgical History of the Rebellion. Part 2. Washington, DC: US Army; 1876;11:15.
4. The Medical Department of the United States Army in the World War. In: Surgery, Vol. 2. Washington, DC: US Army; 1927:185.
5. Blalock A. Experimental shock - cause of the low blood pressure produced by muscle injury. Arch Surg. 1930;20:954.
6. Trunkey D. Hypovolemic and traumatic shock. In: Hardaway R, ed. Shock-the Reversible stage of Dying. St. Louis, Mo: Year Book Publisher; 1988:158-177.
7. The World Almanac and Book of Facts 1995. Mahwah, NJ: Funk and Wagnalls; 1995:163.
8. Hardaway RM. Vietnam Wound Analysis. J Trauma. 1978;18:635-643.
9. Balk RA. Pathogenesis and management of multiple organ dysfunction or failure in severe sepsis and septic shock. In: Balk RA, Casey LC, ed. Crit Care Clin. 2000;16:337-352.
10. Baue AE. Multiple organ failure, multiple organ dysfunction syndrome, and systemic inflammatory response syndrome. Why no magic bullets? Arch Surg. 1997;132:703-707.
11. Schwartz RS, Chiu DT, Labin B. Studies on the organization of plasma membrane phospholipids in human erythrocytes In: Krucheber WE, Eaton JW, Aster J, et al. Erythrocyte Membranes 3. Recent Clinical and Experimental Advances. New York, NY: AR Liss; 1984:89-122.
12. Chiu DT, Labin B, Shohet SB. Erythrocyte membrane lipid reorganization during the sickling process. Brit J of Haematol. 1979;41:223-234.
13. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;29(suppl 7):S53-60.
14. Hardaway RM, Burns VW. Mechanism of action of fibrinolysin in the prevention of "irreversible" hemorrhagic shock. Ann Surg. 1963;157:305-309.
15. Hardaway RM, Williams CH, Marvasti M, et al. Prevention of adult respiratory distress syndrome with plasminogen activator in pigs. Crit Care Med. 1990;18:1413-1418.
16. Hardaway RM. Traumatic and septic shock alias post trauma critical illness. Br J Surg. 1998;85:1473-1479.
17. Hardaway RM, Williams CH, and Vasquez Y. Disseminated intravascular coagulation in sepsis. Sem Thromb Hemost. 2001;27:577-583.